Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Relations Between Exhaled Nitric Oxide And Measures Of Disease Activity Among Children With Mild-to-moderate Asthma.

R. Covar, S. Szefler, R. Martin, D. Sundstrom, P. Silkoff, J. Murphy, D. Young, J. Spahn
Published 2003 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE Exhaled nitric oxide (FE(NO)) was evaluated in children with asthma after 4 to 6 years of treatment with budesonide, nedocromil, or albuterol as needed. STUDY DESIGN FE(NO), spirometry, total eosinophil count, and serum eosinophil cationic protein levels were obtained from 118 children at the Denver site of the Childhood Asthma Management Program upon completion of treatment and after a 2- to 4-month washout. RESULTS Budesonide-treated patients had significantly lower median (1st, 3rd quartile) FE(NO) (21.5 [13.2, 84.4] vs 62.5 [26.2, 115.0] ppb, P <.01) and eosinophil cationic protein levels (17.4 [10.1, 24.3] vs 24.0 [15.4, 33.9] mg/dL, P =.05) compared with placebo, whereas no differences were noted between nedocromil and placebo groups. After washout, FE(NO) levels were similar between the three treatments. FE(NO) levels significantly correlated with degree of bronchial hyperresponsiveness, bronchodilator reversibility, allergen skin prick tests, serum IgE, and total eosinophil count. FE(NO) levels were also higher in patients with nocturnal symptoms and in patients requiring beta-agonist use at least once weekly. CONCLUSIONS Budesonide therapy was more effective than nedocromil in reducing FE(NO). Unfortunately, the effects of long-term budesonide were not sustained after its discontinuation. FE(NO) may be a complementary tool to current practice guidelines in assessing asthma control and medication response.
This paper references
10.1183/09031936.96.09020196
Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients.
S. Kharitonov (1996)
10.1136/thx.54.5.403
Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
E. V. van Rensen (1999)
10.1016/S0140-6736(05)80083-2
Induction of nitric oxide synthase in asthma
Q. Hamid (1993)
10.1016/S0954-6111(98)90189-5
Exhaled nitric oxide; relationship to clinicophysiological markers of asthma severity.
M. Alali (1998)
10.1164/AJRCCM.155.1.9001322
Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.
P. Silkoff (1997)
10.1542/PEDS.110.4.797
Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma.
P. Sharek (2002)
10.1183/09031936.99.13614029
Childhood asthma: exhaled nitric oxide in relation to clinical symptoms.
A. Artlich (1999)
10.1164/AJRCCM.153.1.8542158
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.
S. Kharitonov (1996)
10.1136/thx.53.2.91
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
A. Jatakanon (1998)
10.1016/0167-5699(95)80128-6
Nitric oxide and asthmatic inflammation.
P. Barnes (1995)
10.1164/AJRCCM/148.5.1252
Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group.
H. J. Waalkens (1993)
10.1034/j.1399-3003.1999.13f25.x
Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.
G. Piacentini (1999)
10.1002/1099-0496(200011)30:5<385::AID-PPUL4>3.0.CO;2-#
Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma
Angel Colón-Semidey (2000)
10.1056/NEJM199010113231505
Eosinophilic inflammation in asthma.
J. Bousquet (1990)
10.1136/BMJ.2.4741.1187
Eosinophil Counting: A Modification of Pilot's Method
J. Macfarlane (1951)
10.1111/J.1745-7599.2003.TB00256.X
Guidelines for the diagnosis and management of asthma: update on selected topics 2002.
D. Judd (2003)
10.1164/ARRD.1985.131.4.599
Damage of the airway epithelium and bronchial reactivity in patients with asthma.
L. Laitinen (1985)
10.1056/NEJM200010123431501
Long-term effects of budesonide or nedocromil in children with asthma.
S. Szefler (2000)
10.1016/S0197-2456(98)00044-0
The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.
G. Shapiro (1999)
10.1034/J.1399-3003.1999.13B17.X
Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma.
M. Silvestri (1999)
10.1164/AJRCCM.151.6.7767511
Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation.
J. Spahn (1995)
10.1056/NEJM199201303260504
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
D. Robinson (1992)
10.1164/AJRCCM.159.4.9806052
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.
J. Sont (1999)
10.1067/MAI.2000.109618
Exhaled nitric oxide levels correlate with measures of disease control in asthma.
J. Sippel (2000)
10.1034/J.1399-3003.1999.14D27.X
Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma.
C. Ulrik (1999)
10.1097/00000441-195507000-00017
Diagnostic laboratory hematology
G. Cartwright (1955)



This paper is referenced by
10.1016/j.jaci.2009.05.036
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.
R. Gruchalla (2009)
10.3389/fped.2018.00196
Measuring Airway Inflammation in Asthmatic Children
L. Tenero (2018)
Ocena parametrów klinicznych, spirometrycznych i stężenia tlenku azotu w powietrzu wydychanym u dzieci chorych na astmę w czasie rocznej obserwacji prospektywnej
Kaczmarek Monika (2012)
10.1111/j.1398-9995.2009.01971.x
Relation between inflammation and symptoms in asthma
I. Tillie-Leblond (2009)
10.1007/s40521-016-0106-0
Biomarkers for the Phenotyping and Monitoring of Asthma in Children
A. James (2016)
Labeling Summary/Package Insert NIOX VERO® – US English
NIOX VERO (2017)
10.1016/J.JACI.2005.09.029
Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma.
P. Silkoff (2005)
10.4168/AARD.2015.3.1.40
Relationships of bronchodilator response with asthma control and fractional exhaled nitric oxide in children with atopic asthma
J. Park (2015)
10.1002/ppul.21144
Association among lung function, exhaled nitric oxide, and the CAN questionnaire to assess asthma control in children
O. Sardón-Prado (2010)
10.1016/j.jaci.2010.03.023
Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers.
J. Debley (2010)
10.1002/PPUL.20747
Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function
Maria Luisa Z Paro-Heitor (2008)
10.1378/CHEST.129.6.1492
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
A. Gelb (2006)
10.1164/rccm.200801-060ST
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.
H. Reddel (2009)
The Role of Exhaled Nitric Oxide in Childhood Asthma Management
Република Македонија ()
10.1183/09031936.00049610
Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children
D. Suh (2010)
10.1016/j.coph.2008.04.001
The clinical utility of biomarkers in asthma and COPD.
N. Snell (2008)
10.1016/b978-1-4377-1984-0.00047-4
Wheezing in Older Children
C. Kercsmar (2012)
10.1097/ACI.0b013e328335ce48
Lung function measurement in the assessment of childhood asthma: recent important developments
S. Galant (2010)
10.1016/B978-032304289-5.10006-2
Chapter 6 – How Do You Diagnose Asthma in the Child?
J. Spahn (2008)
10.1186/2049-6958-8-50
The value of FeNO measurement in childhood asthma: uncertainties and perspectives
G. Ferrante (2013)
10.1016/j.anai.2013.05.019
Leptin and urinary leukotriene E4 and 9α,11β-prostaglandin F2 release after exercise challenge.
H. Baek (2013)
10.1002/PPUL.70035
Exhaled gas analysis and airway inflammation
E. Baraldi (2004)
10.1097/01.all.0000216854.95323.91
Monitoring of asthma control in children
C. Dinakar (2006)
Inhaled corticosteroids in asthma management.
Patrick O Sobande (2008)
10.1007/978-4-431-88317-3_14
Mechanisms of Nocturnal Asthma
K. Kowal (2009)
10.1016/B978-032304289-5.10020-7
Chapter 20 – Management of Persistent Asthma in Children
A. Patel (2008)
10.1111/all.12599
Serum periostin levels correlate with airway hyper‐responsiveness to methacholine and mannitol in children with asthma
J-S Song (2015)
10.3889/MMEJ.2015.50014
The Role of Exhaled Nitric Oxide in Childhood Asthma Management
V. Micevska (2015)
E-NOSE: AN INNOVATIVE TECHNOLOGY TO EVALUATE DIFFERENT RESPIRATORY PATTERNS IN PEDIATRIC POPULATION
Degli Studi (2018)
10.1002/9781118785614.CH11
Upper Airway Disease
A. Paul (2013)
Non-invasive markers of airway inflammation in the clinical assessment and management of asthma
D. Shaw (2007)
10.1002/PPUL.20215
Quantitative computed tomography detects peripheral airway disease in asthmatic children
N. Jain (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar